In contrast, sulforaphane appears to exert broader effects on hypoxia-associated tumor phenotypes, including mammosphere formation and tumor burden reduction, and benefits from comparatively favorable absorption; nonetheless, interindividual variability and inconsistent biomarker modulation in clinical trials limit definitive conclusions regarding its anti–HIF-1α efficacy. Here, HIF1A is linked to neoplasm.